Evidence map›Paper›PMID 36694950›Full record

ArticleMedical mycology2023

Candida khanbhai sp. nov., a new clinically relevant yeast within the Candida haemulonii species complex.

Auke W de Jong, Khaled Al-Obaid, Ratna Mohd Tap, Bert Gerrits van den Ende, Marizeth Groenewald, Leena Joseph, Suhail Ahmad, Ferry Hagen

Abstract read
In one paragraph

Article in Medical mycology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Silent Outbreaks ofAntibiotics (Basel, Switzerland) · 2026
    Article
  4. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  5. Name changes for fungi of medical importance, 2022-2024.Journal of clinical microbiology · 2025
    Review
  6. Article
  7. Review
  8. The multidrug-resistantCurrent research in microbial sciences · 2025
    Review
  9. Article
  10. Review
  11. Biological and genomic analyses ofNew microbes and new infections · 2024
    Article
  12. Article
  13. Review
  14. Global Epidemiology of Invasive Infections by UncommonJournal of fungi (Basel, Switzerland) · 2024
    Review
  15. Article
  16. Article
  17. Zoonoses (Shannon, Ireland) · 2023
    Article
  18. Strategies to Prevent Transmission ofCurrent fungal infection reports · 2023
    Review
  19. Spectrum and management of rareTherapeutic advances in infectious disease
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Auke W de JongDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.ORCID 0000-0002-0914-4612
Khaled Al-ObaidDepartment of Microbiology, Mubarak Al-Kabir Hospital, Jabriya, Kuwait.
Ratna Mohd TapMycology Section, Bacteriology Unit, Infectious Disease Research Centre, Institute for Medical Research, National Institutes of Health, Selangor, Malaysia.ORCID 0000-0002-9288-8988
Bert Gerrits van den EndeDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.ORCID 0000-0003-4439-3494
Marizeth GroenewaldDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.ORCID 0000-0003-0835-5925
Leena JosephDepartment of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
Suhail AhmadDepartment of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.ORCID 0000-0003-3492-4781
Ferry HagenDepartment of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.ORCID 0000-0002-5622-1916

Funding

CDC
6 · The paper itself

Abstract

Invasive fungal infections caused by non-albicans Candida species are increasingly reported. Recent advances in diagnostic and molecular tools enabled better identification and detection of emerging pathogenic yeasts. The Candida haemulonii species complex accommodates several rare and recently described pathogenic species, C. duobushaemulonii, C. pseudohaemulonii, C. vulturna, and the most notorious example is the outbreak-causing multi-drug resistant member C. auris. Here, we describe a new clinically relevant yeast isolated from geographically distinct regions, representing the proposed novel species C. khanbhai, a member of the C. haemulonii species complex. Moreover, several members of the C. haemulonii species complex were observed to be invalidly described, including the clinically relevant species C. auris and C. vulturna. Hence, the opportunity was taken to correct this here, formally validating the names of C. auris, C. chanthaburiensis, C. konsanensis, C. metrosideri, C. ohialehuae, and C. vulturna.

Indexed as

CandidiasisInvasive Fungal InfectionsAnimalsAntifungal AgentsCandidaSaccharomyces cerevisiaeAntifungal Agentsantifungal resistantCandida aurisCandida haemulonii species complexCandida vulturnaemerging pathogenmisidentification

Identifiers

PMID36694950
PMCPMC9936790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.